Vetanova Stock

Vetanova FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Vetanova (VTNA) as of Aug 14, 2026 is 4.57 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 116.67 % — a change of -96.08% (lower).

FCF Conversion

4.57 %

YoY

-96.08%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Vetanova is 2026 4.57 % . FCF Conversion Rate (FCF/EBITDA) of Vetanova was 2025 116.67 % . It decreases by -96.08% lower compared to the previous year.
Access this data via the Eulerpool API

Vetanova Stock analysis

What does Vetanova do? Vetanova Inc is a company that specializes in the production of veterinary medicines and has its roots in the animal health industry. It was founded in 2005 by a team of experienced veterinarians with the aim of improving the treatment of pets and livestock through the development of innovative products. Vetanova's business model is based on the manufacturing and marketing of veterinary medicines, as well as the sale of pet food and care products. The company's different divisions include both the development and production of prescription drugs and over-the-counter products, which are sold in specialty stores and online shops. Vetanova has specialized particularly in the development of medicines against infections, parasites, and inflammation. The company relies on a combination of traditional and modern manufacturing processes to bring high-quality products to the market. In addition to manufacturing medicines, Vetanova also offers a variety of products for the care and nutrition of pets. These include dietary supplements, pet care products, and specialized pet food tailored to their needs. As a company dedicated to the quality of its products and the health of animals, Vetanova works closely with veterinarians and breeders to ensure that its products meet high standards. In this regard, Vetanova also strives to intensify collaboration with scientific institutions to improve and further develop the effectiveness of its products. Animal welfare is also an important factor for Vetanova. The company advocates for the protection and well-being of animals and supports projects that help animals in need. In summary, Vetanova is a successful and renowned company that has specialized in the development and production of veterinary medicines since 2005. The company offers a wide range of products, including both prescription and over-the-counter products, targeting both pets and livestock. Vetanova is dedicated to the health of animals and focuses on collaborating with veterinarians and breeders to improve the effectiveness and quality of its products. Animal welfare and sustainability are other important aspects emphasized by Vetanova. Vetanova is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vetanova stock

FCF Conversion Rate (FCF/EBITDA) of Vetanova is 4.57 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Vetanova changed from 116.67 % to 4.57 %, representing a -96.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Vetanova since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Vetanova with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Vetanova

All Key Metrics — Vetanova